These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29304392)

  • 21. Changes in platelet reactivity following aspirin treatment for pre-eclampsia.
    Sullivan MH; Elder MG
    Br J Obstet Gynaecol; 1993 Jun; 100(6):542-5. PubMed ID: 8334089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.
    Harrington K; Kurdi W; Aquilina J; England P; Campbell S
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):13-8. PubMed ID: 10776007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin.
    Bower SJ; Harrington KF; Schuchter K; McGirr C; Campbell S
    Br J Obstet Gynaecol; 1996 Jul; 103(7):625-9. PubMed ID: 8688387
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Mone F; Mulcahy C; McParland P; Breathnach F; Downey P; McCormack D; Culliton M; Stanton A; Cody F; Morrison JJ; Daly S; Higgins J; Cotter A; Hunter A; Tully EC; Dicker P; Alfirevic Z; Malone FD; McAuliffe FM
    BMJ Open; 2018 Jul; 8(7):e022056. PubMed ID: 30056389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with low-dose acetylsalicylic acid can reduce risk of pre-eclampsia in high-risk pregnant women].
    Käehne LV; Rørbye C
    Ugeskr Laeger; 2017 Apr; 179(14):. PubMed ID: 28416068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin non-response in pregnant women at increased risk of pre-eclampsia.
    Vinogradov R; Boag C; Murphy P; McGeeney D; Kunadian V; Robson SC
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():292-297. PubMed ID: 33039837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Influence of Nonadherence With Prophylactic Aspirin in Preventing Preeclampsia in High-Risk Pregnancies: A Multicenter, Prospective, Observational Cohort Study.
    Shanmugalingam R; Wang X; Motum P; Fulcher I; Lee G; Kumar R; Hennessy A; Makris A
    Hypertension; 2020 Apr; 75(4):1125-1132. PubMed ID: 32114852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
    Askie LM; Duley L; Henderson-Smart DJ; Stewart LA;
    Lancet; 2007 May; 369(9575):1791-1798. PubMed ID: 17512048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
    Steyn DW; Odendaal HJ
    Lancet; 1997 Nov; 350(9087):1267-71. PubMed ID: 9357405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis.
    Rossi AC; Mullin PM
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):9-16. PubMed ID: 21641104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.
    Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G
    Platelets; 2016; 27(3):254-61. PubMed ID: 26367099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Titration of antiplatelet treatment in pregnant women at risk of preeclampsia.
    Sullivan MH; Clark NA; de Swiet M; Nelson-Piercy C; Elder MG
    Thromb Haemost; 1998 Apr; 79(4):743-6. PubMed ID: 9569185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.
    Odibo AO; Goetzinger KR; Odibo L; Tuuli MG
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):414-8. PubMed ID: 25914193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.].
    Reis de Carvalho C; Bigotte Vieira M; Costa J; Vaz Carneiro A
    Acta Med Port; 2021 Dec; 34(12):810-814. PubMed ID: 34989670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1).
    Subtil D; Goeusse P; Puech F; Lequien P; Biausque S; Breart G; Uzan S; Marquis P; Parmentier D; Churlet A;
    BJOG; 2003 May; 110(5):475-84. PubMed ID: 12742332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review.
    Coomarasamy A; Honest H; Papaioannou S; Gee H; Khan KS
    Obstet Gynecol; 2003 Jun; 101(6):1319-32. PubMed ID: 12798543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin Use in Women: Current Perspectives and Future Directions.
    Sarma A; Scott NS
    Curr Atheroscler Rep; 2016 Dec; 18(12):74. PubMed ID: 27807733
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.